Found: 30
Select item for more details and to access through your institution.
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Pneumothorax Complicating Fatal Bronchiolitis obliterans Organizing Pneumonia.
- Published in:
- Respiration, 1999, v. 66, n. 3, p. 266, doi. 10.1159/000029371
- By:
- Publication type:
- Article
Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 155, doi. 10.1016/j.cllc.2011.03.015
- By:
- Publication type:
- Article
Second-line Paclitaxel/Carboplatin Versus Vinorelbine/Carboplatin in Patients Who Have Advanced Non-Small-Cell Lung Cancer Pretreated With Non-Platinum-Based Chemotherapy: A Multicenter Randomized Phase II Study.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 2, p. 100, doi. 10.1016/j.cllc.2011.03.004
- By:
- Publication type:
- Article
Reporting Liver Cancer Trends in the Island of Crete, Greece: Results from a Geo-Epidemiological Study.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 16, p. 10166, doi. 10.3390/ijerph191610166
- By:
- Publication type:
- Article
Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0252537
- By:
- Publication type:
- Article
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 119, n. 1, p. 95, doi. 10.1007/s10549-009-0468-0
- By:
- Publication type:
- Article
A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 35, doi. 10.1007/s00280-011-1663-3
- By:
- Publication type:
- Article
A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 415, doi. 10.1007/s00280-010-1508-5
- By:
- Publication type:
- Article
A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1239, doi. 10.1007/s00280-010-1415-9
- By:
- Publication type:
- Article
Second-line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 361, doi. 10.1007/s00280-010-1329-6
- By:
- Publication type:
- Article
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 785, doi. 10.1007/s00280-009-0928-6
- By:
- Publication type:
- Article
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 3, p. 449, doi. 10.1007/s00280-007-0624-3
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 6, p. 742, doi. 10.1007/s00280-006-0236-3
- By:
- Publication type:
- Article
Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 466, doi. 10.1007/s00280-004-0912-0
- By:
- Publication type:
- Article
BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 5, p. 1334, doi. 10.1002/ijc.32903
- By:
- Publication type:
- Article
Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group.
- Published in:
- Annals of Gastroenterology, 2018, v. 31, n. 1, p. 65, doi. 10.20524/aog.2017.0215
- By:
- Publication type:
- Article
Favorable Clinical Course of Patients Experiencing Bevacizumab-Induced Proteinuria.
- Published in:
- Case Reports in Oncology, 2010, v. 3, n. 3, p. 368, doi. 10.1159/000321630
- By:
- Publication type:
- Article
MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.
- Published in:
- Biomedicines, 2021, v. 9, n. 4, p. 421, doi. 10.3390/biomedicines9040421
- By:
- Publication type:
- Article
Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2754, doi. 10.1002/cncr.28132
- By:
- Publication type:
- Article
Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma.
- Published in:
- 2010
- By:
- Publication type:
- Report
Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Study.
- Published in:
- Oncology, 2009, v. 76, n. 2, p. 112, doi. 10.1159/000192586
- By:
- Publication type:
- Article
A Dose Escalation Study of the Biweekly Administration of Paclitaxel, Oxaliplatin and Capecitabine in Patients with Advanced Solid Tumors.
- Published in:
- Oncology, 2007, v. 72, n. 1/2, p. 45, doi. 10.1159/000111088
- By:
- Publication type:
- Article
A Multicenter Phase II Study of Docetaxel in Combination with Gefitinib in Gemcitabine-Pretreated Patients with Advanced/Metastatic Pancreatic Cancer.
- Published in:
- Oncology, 2006, v. 71, n. 3/4, p. 159, doi. 10.1159/000106064
- By:
- Publication type:
- Article
Oxaliplatin as First-Line Treatment in Inoperable Biliary Tract Carcinoma.
- Published in:
- Oncology, 2006, v. 70, n. 4, p. 280, doi. 10.1159/000096249
- By:
- Publication type:
- Article
Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-277
- By:
- Publication type:
- Article
Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-277
- By:
- Publication type:
- Article
Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
- Published in:
- BMC Cancer, 2007, v. 7, p. 91, doi. 10.1186/1471-2407-7-91
- By:
- Publication type:
- Article